Cargando…

Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry

Surgical excision is essential for management of the rare and aggressive neoplasm adrenal cortical carcinoma (ACC). Five-year overall survival (OS) after surgery for ACC is dependent on disease stage, but for all stages the risk of death declines with time after surgery. We calculated the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Wen-jun, Zhu, Yao, Dai, Bo, Zhang, Hai-liang, Shi, Guo-hai, Shen, Yi-jun, Zhu, Yi-ping, Ye, Ding-wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792603/
https://www.ncbi.nlm.nih.gov/pubmed/26510907
_version_ 1782421273313280000
author Xiao, Wen-jun
Zhu, Yao
Dai, Bo
Zhang, Hai-liang
Shi, Guo-hai
Shen, Yi-jun
Zhu, Yi-ping
Ye, Ding-wei
author_facet Xiao, Wen-jun
Zhu, Yao
Dai, Bo
Zhang, Hai-liang
Shi, Guo-hai
Shen, Yi-jun
Zhu, Yi-ping
Ye, Ding-wei
author_sort Xiao, Wen-jun
collection PubMed
description Surgical excision is essential for management of the rare and aggressive neoplasm adrenal cortical carcinoma (ACC). Five-year overall survival (OS) after surgery for ACC is dependent on disease stage, but for all stages the risk of death declines with time after surgery. We calculated the effect of post-surgical duration on conditional survival (CS) among ACC patients. A total of 641 patients with M0 ACC were selected from the Surveillance, Epidemiology, and End Results (SEER) registry (1988–2012). OS for the entire cohort at 1, 2, 3, 4, 5 and 6 years was 81.4%, 66.8%, 56.3%, 50.3%, 47.2% and 44.3%, respectively. CS for an additional year given prior survival for 0, 1, 2, 3, 4 or 5 years was 81.4%, 81.1%, 83.0%, 87.5%, 93.4% and 93.4%, respectively. Age, tumor stage, tumor grade and marital status affected OS and CS. Increases in 1-year CS over time were more pronounced in patients with poorer prognostic factors. With longer follow-up, tumor stage- and grade-dependent differences in CS decreased or even disappeared. CS may provide more meaningful life expectancy predictions for survivors of ACC than conventional survival analysis.
format Online
Article
Text
id pubmed-4792603
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47926032016-03-29 Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry Xiao, Wen-jun Zhu, Yao Dai, Bo Zhang, Hai-liang Shi, Guo-hai Shen, Yi-jun Zhu, Yi-ping Ye, Ding-wei Oncotarget Clinical Research Paper Surgical excision is essential for management of the rare and aggressive neoplasm adrenal cortical carcinoma (ACC). Five-year overall survival (OS) after surgery for ACC is dependent on disease stage, but for all stages the risk of death declines with time after surgery. We calculated the effect of post-surgical duration on conditional survival (CS) among ACC patients. A total of 641 patients with M0 ACC were selected from the Surveillance, Epidemiology, and End Results (SEER) registry (1988–2012). OS for the entire cohort at 1, 2, 3, 4, 5 and 6 years was 81.4%, 66.8%, 56.3%, 50.3%, 47.2% and 44.3%, respectively. CS for an additional year given prior survival for 0, 1, 2, 3, 4 or 5 years was 81.4%, 81.1%, 83.0%, 87.5%, 93.4% and 93.4%, respectively. Age, tumor stage, tumor grade and marital status affected OS and CS. Increases in 1-year CS over time were more pronounced in patients with poorer prognostic factors. With longer follow-up, tumor stage- and grade-dependent differences in CS decreased or even disappeared. CS may provide more meaningful life expectancy predictions for survivors of ACC than conventional survival analysis. Impact Journals LLC 2015-10-14 /pmc/articles/PMC4792603/ /pubmed/26510907 Text en Copyright: © 2015 Xiao et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Clinical Research Paper
Xiao, Wen-jun
Zhu, Yao
Dai, Bo
Zhang, Hai-liang
Shi, Guo-hai
Shen, Yi-jun
Zhu, Yi-ping
Ye, Ding-wei
Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
title Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
title_full Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
title_fullStr Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
title_full_unstemmed Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
title_short Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
title_sort conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
topic Clinical Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792603/
https://www.ncbi.nlm.nih.gov/pubmed/26510907
work_keys_str_mv AT xiaowenjun conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry
AT zhuyao conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry
AT daibo conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry
AT zhanghailiang conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry
AT shiguohai conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry
AT shenyijun conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry
AT zhuyiping conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry
AT yedingwei conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry